A Study to Assess Deucravacitinib Post-marketing Surveillance in Participants With Psoriasis in Japan
Clinical trial NCT05633264 · COMPLETED
Trial details
- NCT number
- NCT05633264
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-12-05
- Primary completion
- 2025-05-28
- Enrollment
- 369
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.